We also explored the molecular mechanisms of RRM2 in the context of different cancers using a series of factors, including gene expression, clinical correlation, survival analysis, genetic alterations, immune infiltration, immune checkpoints, enrichment analysis, and potential drug prediction. This evidence concerns the gene RRM2 and cancer.